227 related articles for article (PubMed ID: 33970103)
1. KSR1- and ERK-dependent translational regulation of the epithelial-to-mesenchymal transition.
Rao C; Frodyma DE; Southekal S; Svoboda RA; Black AR; Guda C; Mizutani T; Clevers H; Johnson KR; Fisher KW; Lewis RE
Elife; 2021 May; 10():. PubMed ID: 33970103
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
3. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
[TBL] [Abstract][Full Text] [Related]
4. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
[TBL] [Abstract][Full Text] [Related]
5. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling.
Yan Z; Yin H; Wang R; Wu D; Sun W; Liu B; Su Q
Acta Histochem; 2014 Apr; 116(3):527-33. PubMed ID: 24360977
[TBL] [Abstract][Full Text] [Related]
7. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
[TBL] [Abstract][Full Text] [Related]
8. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
[TBL] [Abstract][Full Text] [Related]
9. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of epithelial to mesenchymal transition by E-cadherin up-regulation via repression of slug transcription and inhibition of E-cadherin degradation: dual role of scaffold/matrix attachment region-binding protein 1 (SMAR1) in breast cancer cells.
Adhikary A; Chakraborty S; Mazumdar M; Ghosh S; Mukherjee S; Manna A; Mohanty S; Nakka KK; Joshi S; De A; Chattopadhyay S; Sa G; Das T
J Biol Chem; 2014 Sep; 289(37):25431-44. PubMed ID: 25086032
[TBL] [Abstract][Full Text] [Related]
11. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
12. PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
Zhu G; Li X; Guo B; Ke Q; Dong M; Li F
Oncogene; 2016 Apr; 35(15):1943-54. PubMed ID: 26212009
[TBL] [Abstract][Full Text] [Related]
13. Numerical modelling of WNT/β-catenin signal pathway in characterization of EMT of colorectal carcinoma cell lines after treatment with Pt(IV) complexes.
Šeklić DS; Đukić T; Milenković D; Jovanović MM; Živanović MN; Marković Z; Filipović N
Comput Methods Programs Biomed; 2022 Nov; 226():107158. PubMed ID: 36198204
[TBL] [Abstract][Full Text] [Related]
14. Metformin mediated reversal of epithelial to mesenchymal transition is triggered by epigenetic changes in E-cadherin promoter.
Banerjee P; Surendran H; Chowdhury DR; Prabhakar K; Pal R
J Mol Med (Berl); 2016 Dec; 94(12):1397-1409. PubMed ID: 27534967
[TBL] [Abstract][Full Text] [Related]
15. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
[TBL] [Abstract][Full Text] [Related]
16. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
Gasior K; Hauck M; Wilson A; Bhattacharya S
Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
[TBL] [Abstract][Full Text] [Related]
17. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.
Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM
Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982
[TBL] [Abstract][Full Text] [Related]
18. ΔNp63α Promotes Breast Cancer Cell Motility through the Selective Activation of Components of the Epithelial-to-Mesenchymal Transition Program.
Dang TT; Esparza MA; Maine EA; Westcott JM; Pearson GW
Cancer Res; 2015 Sep; 75(18):3925-35. PubMed ID: 26292362
[TBL] [Abstract][Full Text] [Related]
19. Identification of epithelial stromal interaction 1 as a novel effector downstream of Krüppel-like factor 8 in breast cancer invasion and metastasis.
Li T; Lu H; Shen C; Lahiri SK; Wason MS; Mukherjee D; Yu L; Zhao J
Oncogene; 2014 Sep; 33(39):4746-55. PubMed ID: 24096480
[TBL] [Abstract][Full Text] [Related]
20. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
